{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:04:50Z","timestamp":1768194290467,"version":"3.49.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["156175"],"award-info":[{"award-number":["156175"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>This study investigates the effects of the anticancer drug docetaxel (DTX) and its timing of administration on tumor development and resultant bone quality in a rodent model, considering both healthy animals and those with osteolytic bone metastases secondary to intra-cardiac injection (d0) of HeLa cells. Healthy and tumor-bearing rats were treated with DTX on d7 or d14 and compared to the control (no treatment) and an additional cohort treated with Zoledronic acid (ZOL). Notably, DTX administration on d7 markedly curtailed tumor growth, as evidenced by bioluminescence and histological analysis, indicating its effectiveness in reducing bone metastases. Bone metastases were more established in animals treated with later DTX administration and ZOL, but still reduced compared to no treatment. When considering bone quality, we found that both the organic and mineral phases of bone are impacted by DTX treatment. Tumor-bearing animals exhibited decreased hydroxyproline\/proline ratios reflecting change in collagen metabolism compared to healthy controls, but these decreases were only significant with no treatment or DTX administration on d14. This suggests a positive impact of early DTX treatment similar to ZOL on bone quality from an organic perspective. As well, increased CaMean and CaPeak reflecting the degree of calcification was found in healthy rats treated early with DTX, similar to that seen with ZOL compared to the tumor-bearing treated groups. Overall, early docetaxel administration reduced tumor formation and improved bone quality, suggesting its potential benefit in managing bone metastases.<\/jats:p>","DOI":"10.1371\/journal.pone.0320134","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T17:42:37Z","timestamp":1744911757000},"page":"e0320134","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Temporal effect of docetaxel on bone quality in a rodent model of vertebral metastases"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-2381","authenticated-orcid":true,"given":"Margarete K.","family":"Akens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammedayaz","family":"Rangrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7680-5903","authenticated-orcid":true,"given":"Allison","family":"Tolgyesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6220-4557","authenticated-orcid":true,"given":"Thomas L.","family":"Willett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cari M.","family":"Whyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"1","key":"pone.0320134.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007632-199001000-00001","article-title":"Spinal metastases: the obvious, the occult, and the impostors","volume":"15","author":"DA Wong","year":"1990","journal-title":"Spine (Phila Pa 1976)"},{"issue":"4","key":"pone.0320134.ref002","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2010.227","article-title":"Bone metastasis: mechanisms and therapeutic opportunities","volume":"7","author":"LJ Suva","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"pone.0320134.ref003","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa050434","article-title":"A pooled analysis of bone marrow micrometastasis in breast cancer","volume":"353","author":"S Braun","year":"2005","journal-title":"N Engl J Med"},{"key":"pone.0320134.ref004","first-page":"327253","article-title":"Castration-resistant prostate cancer: mechanisms, targets, and treatment","author":"TMS Amaral","year":"2012","journal-title":"Prostate Cancer"},{"issue":"5","key":"pone.0320134.ref005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0305-7372(03)00097-5","article-title":"Mode of action of docetaxel - a basis for combination with novel anticancer agents","volume":"29","author":"RS Herbst","year":"2003","journal-title":"Cancer Treat Rev"},{"issue":"15","key":"pone.0320134.ref006","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"IF Tannock","year":"2004","journal-title":"N Engl J Med"},{"issue":"20","key":"pone.0320134.ref007","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.275.20.14838","article-title":"Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1\/2 AND p38 mitogen-activated protein kinase pathways","volume":"275","author":"K Subbaramaiah","year":"2000","journal-title":"J Biol Chem"},{"issue":"11","key":"pone.0320134.ref008","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1139\/y2012-123","article-title":"PGE\u2082 and BMP-2 in bone and cartilage metabolism: 2 intertwining pathways","volume":"90","author":"M Haversath","year":"2012","journal-title":"Can J Physiol Pharmacol"},{"issue":"6","key":"pone.0320134.ref009","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00301951","article-title":"Taxol inhibits osteoclastic bone resorption","volume":"57","author":"TJ Hall","year":"1995","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"pone.0320134.ref010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00774-008-0013-y","article-title":"Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners","volume":"27","author":"M Takahashi","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"pone.0320134.ref011","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0093-7754(01)90263-5","article-title":"Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment","volume":"28","author":"GR Mundy","year":"2001","journal-title":"Semin Oncol"},{"issue":"3","key":"pone.0320134.ref012","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.coph.2006.03.005","article-title":"Recent advances in understanding the mechanism of action of bisphosphonates","volume":"6","author":"FP Coxon","year":"2006","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"pone.0320134.ref013","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cncr.25529","article-title":"Zoledronic acid use in cancer patients: more than just supportive care?","volume":"117","author":"R Coleman","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"pone.0320134.ref014","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-009-0356-7","article-title":"Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin)","volume":"119","author":"MK Akens","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"pone.0320134.ref015","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/jor.23248","article-title":"Osteolytic and mixed cancer metastasis modulates collagen and mineral parameters within rat vertebral bone matrix","volume":"34","author":"MV Burke","year":"2016","journal-title":"J Orthop Res"},{"issue":"1","key":"pone.0320134.ref016","first-page":"131","article-title":"Inhibition of in vivo tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins","volume":"29","author":"O Engebraaten","year":"2009","journal-title":"Anticancer Res"},{"key":"pone.0320134.ref017","doi-asserted-by":"crossref","first-page":"106382","DOI":"10.1016\/j.jmbbm.2024.106382","article-title":"Treatment affects load to failure and microdamage accumulation in healthy and osteolytic rat vertebrae","volume":"151","author":"A Tolgyesi","year":"2024","journal-title":"J Mech Behav Biomed Mater"},{"issue":"1","key":"pone.0320134.ref018","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-009-0712-7","article-title":"Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue","volume":"124","author":"E Won","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"1\u20132","key":"pone.0320134.ref019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-4347(97)00391-5","article-title":"Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run","volume":"703","author":"RA Bank","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"pone.0320134.ref020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2014.01.006","article-title":"Bone embrittlement and collagen modifications due to high-dose gamma-irradiation sterilization","volume":"61","author":"B Burton","year":"2014","journal-title":"Bone"},{"issue":"5","key":"pone.0320134.ref021","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10585-022-10175-6","article-title":"Establishment and image based evaluation of a new preclinical rat model of osteoblastic bone metastases","volume":"39","author":"S Ghomashchi","year":"2022","journal-title":"Clin Exp Metastasis"},{"issue":"11","key":"pone.0320134.ref022","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/jor.24105","article-title":"Mechanical behavior of metastatic vertebrae are influenced by tissue architecture, mineral content, and organic feature alterations","volume":"36","author":"M Burke","year":"2018","journal-title":"J Orthop Res"},{"issue":"1","key":"pone.0320134.ref023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1078155215627502","article-title":"Taxane-induced arthralgia and myalgia: a literature review","volume":"23","author":"N Chiu","year":"2017","journal-title":"J Oncol Pharm Pract"},{"key":"pone.0320134.ref024","doi-asserted-by":"crossref","first-page":"113121","DOI":"10.1016\/j.expneurol.2019.113121","article-title":"Pathogenesis of paclitaxel-induced peripheral neuropathy: a current review of in vitro and in vivo findings using rodent and human model systems","volume":"324","author":"NP Staff","year":"2020","journal-title":"Exp Neurol"},{"key":"pone.0320134.ref025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2407-6-15","article-title":"Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment","volume":"6","author":"KD Brubaker","year":"2006","journal-title":"BMC Cancer"},{"issue":"2","key":"pone.0320134.ref026","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bone.2012.11.014","article-title":"In vitro non-enzymatic ribation reduces post-yield strain accommodation in cortical bone","volume":"52","author":"TL Willett","year":"2013","journal-title":"Bone"},{"key":"pone.0320134.ref027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bone.2016.05.002","article-title":"Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat\u2019s calvaria defect","volume":"89","author":"C Olejnik","year":"2016","journal-title":"Bone"},{"issue":"8","key":"pone.0320134.ref028","doi-asserted-by":"crossref","first-page":"e70960","DOI":"10.1371\/journal.pone.0070960","article-title":"Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs)","volume":"8","author":"G Rong","year":"2013","journal-title":"PLoS One"},{"key":"pone.0320134.ref029","doi-asserted-by":"crossref","first-page":"110214","DOI":"10.1016\/j.intimp.2023.110214","article-title":"The interactions of docetaxel with tumor microenvironment","volume":"119","author":"R Gupta","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"pone.0320134.ref030","first-page":"355","volume-title":"Pentosidine as a biomarker for poor bone quality and elevated fracture risk","author":"JM Pritchard","year":"2017"},{"issue":"3","key":"pone.0320134.ref031","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pdpdt.2014.04.002","article-title":"In vitro and in vivo effects of photodynamic therapy on metastatic breast cancer cells pre-treated with zoledronic acid","volume":"11","author":"MK Akens","year":"2014","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"pone.0320134.ref032","volume-title":"The principles of humane experimental technique [by] W.M.S. Russell and R.L. Burch","author":"WMS Russell","year":"1959"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T17:42:45Z","timestamp":1744911765000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320134"}},"subtitle":[],"editor":[{"given":"Lu","family":"Zhang,","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0320134","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}